By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
TAMPA, Fla. , June 27, 2024 /PRNewswire/ -- The Obesity Action Coalition (OAC) applauds the House Ways and Means Committee for favorably reporting an amended version of the Treat and Reduce Obesity Act with a strong bipartisan vote of ...
Top-Line Data Readout From the Single Ascending Dose Part 1 Expected in the Third Quarter of 2024, and From the Multiple Ascending Dose Part 2 in the First Quarter of 2025 Planned Part 3 Will Assess Total Weight Loss at 24 Weeks, ...
SAN FRANCISCO and SUZHOU, China , June 11, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
Phase 1 Clinical Trial Timelines Significantly Accelerated Top-Line Data Readout from Single Ascending Dose Part 1 Now Expected in the Third Quarter of 2024 First Patient Dosed in the Multiple Ascending Dose Part 2 Expected in the ...
CAMBRIDGE, Mass. , March 8, 2024 /PRNewswire/ -- Regor Therapeutics Group ("Regor"), a clinical-stage global biopharmaceutical company powered by a cutting-edge drug discovery engine and differentiated clinical development pipeline, today ...
WASHINGTON , March 1, 2024 /PRNewswire/ -- To kick off Obesity Care Week 2024, more than 60 advocates with the Obesity Action Coalition (OAC) will gather on Capitol Hill to meet with more than 70 legislators to express the importance of ...
First Patient Expected to be Randomized in the Second Quarter of 2024 CAMBRIDGE, Mass. , Feb. 29, 2024 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on ...
Preclinical Studies Show DA-1726 Elicits Superior Weight Loss Compared to Semaglutide (Wegovy™) and Similar Weight Loss Compared to Tirzepatide (Mounjaro™), While Consuming More Food Initiation of Phase 1 Clinical Trial Expected to Occur ...
CAMBRIDGE, Mass. , Dec. 28, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has submitted an ...
TAMPA, Fla. , Nov. 28, 2023 /PRNewswire/ -- The Obesity Action Coalition (OAC) announces the publication of a "Joint Statement in Support of Closing Gaps in the Drug Approval Process and Drug Labeling for People with Obesity." The ...
Understanding how brain chemistry and food decisions are linked to rising obesity and related health issues.
Study finds a 50% rise in overweight and obesity among adolescents in England, increasing from 22% in 2008–2010 to 33% in 2021–2023.
The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users consuming less processed foods, soda, and certain meats.
Losing a lot of weight provides long-term health benefits, even if some weight is regained.
A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers